Most Common Organism in Healthcare-Associated Intracranial Infections
In healthcare-associated intracranial infections, Staphylococcus aureus and Gram-negative bacilli (particularly Klebsiella pneumoniae) are the predominant pathogens, with the specific organism depending on the type of infection and device involved.
Post-Neurosurgical Brain Abscess
According to the most recent European guidelines, Staphylococcus aureus and Gram-negative bacilli are the primary pathogens in post-neurosurgical brain abscess 1. This is fundamentally different from community-acquired brain abscesses, which are typically caused by oral cavity bacteria (Streptococcus anginosus group, Fusobacterium spp.).
The 2024 ESCMID guidelines specifically recommend empirical treatment of post-neurosurgical brain abscess with a carbapenem combined with vancomycin or linezolid, directly targeting these healthcare-associated organisms 1.
Device-Associated CNS Infections
Recent prospective data from 2025 provides more granular detail on specific organisms:
- Klebsiella pneumoniae is the most frequently isolated organism (51.6%) in CSF drainage device infections, followed by Pseudomonas aeruginosa (19.35%) and Acinetobacter baumannii (9.68%) 2
- K. pneumoniae predominates across all device types: external ventricular drains (42.8%), ventriculoperitoneal shunts (55.55%), and Ommaya reservoirs (83.33%) 2
Site-Specific Patterns in Neurosurgical HAIs
The microbial profile varies by infection site 3, 4:
Urinary Tract Infections (most common HAI):
- Escherichia coli (37.59%)
- Enterococcus (20.83%)
- Candida species (87.50% of fungal isolates)
Pneumonia:
- Klebsiella pneumoniae (25.96%)
- Acinetobacter baumannii (24.03%)
- Pseudomonas aeruginosa (13.46%)
Bloodstream Infections:
- Staphylococcus species (24.22%)
- Candida species (3.10%)
Critical Clinical Considerations
Antimicrobial Resistance
All isolates in recent studies showed multidrug resistance patterns 3, with carbapenemase production being the most frequent resistance mechanism in Enterobacterales (65.7%), followed by ESBL production (62.3%) and MRSA (20%) 5. This underscores why empirical therapy must include broad-spectrum agents with anti-resistant organism coverage.
Mortality Risk Factors
The presence of healthcare-associated infections significantly impacts outcomes, with device-associated infections showing particularly poor prognosis 4. Factors associated with mortality include:
- Pulmonary site infection
- Central venous catheterization
- Mechanical ventilation
- Multiple site infections
Seasonal Variation
Infections peak during hot and humid months, with the highest device-associated infection rates occurring in September (14.28%) 2, suggesting environmental factors play a role in transmission.
Algorithmic Approach to Empirical Coverage
For post-neurosurgical intracranial infections:
- Start carbapenem (covers Gram-negatives including K. pneumoniae, P. aeruginosa, A. baumannii)
- Add vancomycin or linezolid (covers MRSA and coagulase-negative staphylococci)
- Consider local resistance patterns and adjust based on culture results
This differs from community-acquired brain abscess, where 3rd-generation cephalosporin plus metronidazole targets oral anaerobes 1.
The shift from Staphylococcus aureus and coagulase-negative staphylococci (historically dominant in post-surgical infections) to Gram-negative predominance, particularly K. pneumoniae, represents an important epidemiological change in healthcare-associated intracranial infections 2, 5.